HighTower Advisors’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
Other funds holding CODX
BCM
HighTower Advisors's CODX Position: Q3 2022 in Review
HighTower Advisors sold out of Co-Diagnostics (CODX) in Q3 2022, closing a stake of 1,528 shares — an estimated $256K sold.
HighTower Advisors first reported a position in CODX in Q3 2017 and held it in 20 quarters. The position peaked at $905K in Q2 2020. 65 funds tracked by Wall St. Rank hold CODX as of Q3 2022.
- HighTower Advisors reported no remaining Co-Diagnostics position as of Q3 2022 after selling out during the quarter.
- HighTower Advisors sold 1,528 Co-Diagnostics shares in Q3 2022, an estimated $256K.
- HighTower Advisors first reported a position in Co-Diagnostics in Q3 2017 and held it in 20 quarters.
- HighTower Advisors's Co-Diagnostics position peaked at $905K in Q2 2020.
- 65 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2022.
Based on HighTower Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.